INTERNATIONAL PATENT: HANGZHOU SCIWIND BIOSCIENCES CO., LTD., 杭州先为达生物科技股份有限公司, SCIWIND BIOSCIENCES (BEIJING) CO., LTD., 北京先为达生物科技有限公司 FILES APPLICATION FOR "USE OF GLP-1 RECEPTOR AGONIST IN TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS"

Posted On: 2025-01-27

GENEVA, Jan. 27 -- HANGZHOU SCIWIND BIOSCIENCES CO., LTD. (Room 1802, Building 2, Hangzhou East International Business Center, Qiantang DistrictHangzhou, Zhejiang 310018), 杭州先为达生物科技股份有限公司 (中国浙江省杭州市钱塘区杭州东部国际商务中心2幢1802室), SCIWIND BIOSCIENCES (BEIJING) CO., LTD. (Rm. 201, Building 4, No.8 Liangshuihe 2nd Street, BDADaxing District, Beijing 100176), 北京先为达生物科技有限公司 (中国北ߞ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: HANGZHOU SCIWIND BIOSCIENCES CO., LTD., 杭州先为达生物科技股份有限公司, SCIWIND BIOSCIENCES (BEIJING) CO., LTD., 北京先为达生物科技有限公司 FILES APPLICATION FOR "USE OF GLP-1 RECEPTOR AGONIST IN TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS"